{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["44(6)"],"submitter":["Chen LL"],"pubmed_abstract":["<h4>Objective</h4>Since the end of 2019, the coronavirus disease 2019 (COVID-19) virus has infected millions of people, of whom a significant group suffers from sequelae from COVID-19, termed long COVID. As more and more patients emerge with long COVID who have symptoms of fatigue, myalgia and joint pain, we must examine potential biomarkers to find quantifiable parameters to define the underlying mechanisms and enable response monitoring. The aim of this study is to investigate the potential added value of [ 18 F]FDG-PET/computed tomography (CT) for this group of long COVID patients.<h4>Methods</h4>For this proof of concept study, we evaluated [ 18 F]FDG-PET/CT scans of long COVID patients and controls. Two analyses were performed: semi-quantitative analysis using target-to-background rat"],"journal":["Nuclear medicine communications"],"pagination":["495-501"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10171287"],"repository":["biostudies-literature"],"pubmed_title":["Investigating the potential added value of [ 18 F]FDG-PET/CT in long COVID patients with persistent symptoms: a proof of concept study."],"pmcid":["PMC10171287"],"pubmed_authors":["van de Burgt A","van Velden FHP","Smit F","Audhoe RS","Chen LL","de Geus-Oei LF","de Boer SM"],"additional_accession":[]},"is_claimable":false,"name":"Investigating the potential added value of [ 18 F]FDG-PET/CT in long COVID patients with persistent symptoms: a proof of concept study.","description":"<h4>Objective</h4>Since the end of 2019, the coronavirus disease 2019 (COVID-19) virus has infected millions of people, of whom a significant group suffers from sequelae from COVID-19, termed long COVID. As more and more patients emerge with long COVID who have symptoms of fatigue, myalgia and joint pain, we must examine potential biomarkers to find quantifiable parameters to define the underlying mechanisms and enable response monitoring. The aim of this study is to investigate the potential added value of [ 18 F]FDG-PET/computed tomography (CT) for this group of long COVID patients.<h4>Methods</h4>For this proof of concept study, we evaluated [ 18 F]FDG-PET/CT scans of long COVID patients and controls. Two analyses were performed: semi-quantitative analysis using target-to-background rat","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jun","modification":"2025-04-22T00:27:15.166Z","creation":"2025-04-05T19:36:13.762Z"},"accession":"S-EPMC10171287","cross_references":{"pubmed":["36951877"],"doi":["10.1097/MNM.0000000000001689"]}}